O

Oncologica do Brasil | Belem, Brazil

Research site

(Unclaimed)

Location

Avenida Visconde de Souza Franco, 570 - Reduto, Belém, Pará, Brazil

Site insights

Top conditions

Top treatments

Pembrolizumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 2 total trials

A Study of Pembrolizumab (MK-3475) With or Without Maintenance Olaparib in First-line Metastatic Squamous Non-small Cell Lung Cancer (NSCLC, MK-7339-008/KEYLYNK-008)

The current study will compare pembrolizumab (MK-3475) plus maintenance olaparib, vs. pembrolizumab plus maintenance olaparib placebo for the treatme...

Active, not recruiting

Carcinoma, Squamous Cell, Non-small-cell Lung

Drug: Olaparib

Drug: Paclitaxel

Study of Pembrolizumab With Maintenance Olaparib or Maintenance Pemetrexed in First-line (1L) Metastatic Nonsquamous Non-Small-Cell Lung Cancer (NSCLC) (MK-7339-006, KEYLYNK-006)

The current study will compare pembrolizumab (MK-3475) plus maintenance olaparib, versus (vs) pembrolizumab plus maintenance pemetrexed for the treat...

Active, not recruiting

Carcinoma, Nonsquamous Non-small-cell Lung

Drug: Carboplatin

Drug: Cisplatin

Trial sponsors

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms